Clinical trials
Phase 1 Neurocognitive Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer's Disease Expert Lab (ADEL), Inc. | 1 |
| Eli Lilly and Company | 1 |
| LeonaBio | 1 |
| Medical University of South Carolina | 1 |
| NKGen Biotech, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Texas Tech University | 1 |
| University of Maryland, Baltimore | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurocognitive Disorders | 8 |
| Alzheimer Disease | 5 |
| Brain Diseases | 5 |
| Neurodegenerative Diseases | 5 |
| Central Nervous System Diseases | 4 |
| Cognitive Dysfunction | 4 |
| Dementia | 4 |
| Mental Disorders | 4 |
| Nervous System Diseases | 3 |
| Tauopathies | 3 |
Trials
Showing 76 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.